HOME >> BIOLOGY >> NEWS
Blood levels of suspected carcinogen vary by race, ethnicity

Whites have three times higher blood serum levels of perfluorochemicals (PFCs) than Hispanics and two times higher levels than blacks, according to a study scheduled for publication in the April 1 issue of the American Chemical Society's journal, Environmental Science & Technology. The study, by scientists at the Centers for Disease Control and Prevention (CDC) in Atlanta, is the first to detect racial or ethnic differences in levels of PFCs among humans.

PFCs are widely found at low levels in people and at higher levels are suspected of promoting cancer and other health problems in laboratory animals, according to the CDC researchers.

The CDC research team, led by Antonia Calafat, Ph.D., looked for selected PFCs in 54 aggregated blood samples that were collected in 2001 and 2002 as part of the National Health and Nutrition Examination Survey (NHANES). Each aggregated sample contained serum from 34 people, grouped by race, gender and age. Men in all three racial groups had slightly higher blood levels of PFCs than women. Non-Hispanic white males had the highest blood serum levels of most PFCs. However, the CDC team found age had no influence on blood concentrations of these compounds.

Although the researchers can't yet explain why whites had higher blood levels of PFCs, they note that "these differences may be a reflection of greater exposure to PFCs among non-Hispanic whites than among other racial/ethnic groups examined." In addition to environmental exposure, diet, lifestyle and genetic factors could account for elevated PFC blood levels in certain populations, Calafat says. To get a clearer picture of what may be happening, the researchers plan to analyze individual blood samples from NHANES, particularly those taken prior to 2000, the year when leading manufacturer 3M announced a voluntary phase-out of some PFCs.

Introduced in the 1950s, PFCs have long been used in the manufacture of insecticides, non-stick coatings
'"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-4400
American Chemical Society
8-Mar-2006


Page: 1 2

Related biology news :

1. Blood test may help signal tumors remission, return in throat cancer patients
2. Blood sugars manufacture limited by building blocks supply
3. Bloods clotting cells harbor ticking time bombs, finding may help extend blood supply
4. Blood tests may be possible for mental health conditions
5. Cord Blood Registry achieves industry-leading stem cell recovery with new automation technology
6. Blood test predicts cardiac events and death in heart patients
7. Blood clot fibers more elastic than spiders web
8. Blood-compatible nanoscale materials possible using heparin
9. Blood pressure medication may revolutionize treatment of Marfan syndrome
10. Blood conservation strategies take center stage at Emory University Hospital forum
11. Blood test for colon cancer risk to be goal of Hopkins project

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced ... will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional ... Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, ...
(Date:7/2/2020)... ... July 01, 2020 , ... ... phase 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute ... Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research ...
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a ... purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture ... facility located in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... , ... August 12, 2020 , ... ... (EMMA International), a global leader in FDA compliance consulting has been named ... fastest-growing private companies. The list represents a unique look at the most successful ...
(Date:7/31/2020)... ... , ... R3 Stem Cell International is now offering patients the opportunity to ... total, patients may choose which extremities they would like treated. , Several studies have ... 2016). At R3 International, umbilical cord tissue is obtained from a lab with a ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and ... a strategic partnership whereby Catalent will provide support for the development, manufacturing, and ...
(Date:7/22/2020)... ... , ... Join experts from Reed Tech , Gary Saner, Sr. Manager, ... hour live webinar on Thursday, August 13, 2020 at 11am EDT (4pm ... devices. Specifically, for medical devices, the NMPA has departments dealing with medical device registration ...
Breaking Biology Technology:
Cached News: